SCHEMBL2709488

SCHEMBL2709488

COc1cc(F)c(-c2c3ccccc3c(-c3c(F)c(F)c(OC)c(F)c3F)c3c(F)c(F)c(F)c(F)c23)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BUB1 O43683 1/20 0.34
MAOA P21397 2/20 0.33
KDM1A O60341 1/20 0.33
MAOB P27338 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
HSD17B10 Q99714 2/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
TSHR P16473 1/20 0.32
CYP1A1 P04798 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP1B1 Q16678 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2725536 0.94 MAOA (0.35) KDM4EALDH1A1SMN1; SMN2MAOAKDM1A
SCHEMBL2724837 0.91 KDM4E (0.35) KDM4EALDH1A1MAPK1SMN1; SMN2BUB1
SCHEMBL2712620 0.91 KDM4E (0.39) KDM4EALDH1A1MAPK1SMN1; SMN2BUB1
SCHEMBL2724627 0.91 TAAR1 (0.37) KDM4EALDH1A1SMN1; SMN2MAOAKDM1A
SCHEMBL2939722 0.89 TSHR (0.32) ALDH1A1TSHR
SCHEMBL2940921 0.88 MAOA (0.34) KDM4EALDH1A1SMN1; SMN2MAOAKDM1A
SCHEMBL2938082 0.88 TAAR1 (0.37) ALDH1A1HSD17B10TAAR1TSHRCYP1A1
SCHEMBL2934840 0.88 ALDH1A1 (0.45) KDM4EALDH1A1MAPK1SMN1; SMN2BUB1
SCHEMBL2724358 0.88 ALDH1A1 (0.45) KDM4EALDH1A1MAPK1SMN1; SMN2BUB1
SCHEMBL2710697 0.88 NQO2 (0.31) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 KDM4E 670/4885ALDH1A1 34/4885MAPK1 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.